Recommended Articles
Fundraising

Sunfox Technologies Raises $7M Series A to Scale Spandan Portable ECG Platform

By Angeled · October 8, 2026 · Fundraising
Sunfox Technologies Raises $7M Series A to Scale Spandan Portable ECG Platform
Sunfox Technologies Raises $7M Series A to Scale Spandan Portable ECG Platform

Dehradun-based medtech startup Sunfox Technologies has raised $7 million (approximately ₹67 crore) in a Series A funding round to scale its portable cardiac diagnostics platform Spandan across India and expand into international markets.

The Deal

The round was led by investor Ashish Kacholia, Lashit Sanghvi, Alchemy Capital, and 3one4 Capital. 3one4 Capital is an India-based early-stage VC firm founded by Pranav and Siddarth Pai that invests across consumer, enterprise, fintech, healthcare, and deep tech.

The fundraise follows a ₹15 crore (around $1.8 million) round led by Venture Catalysts in 2024. Sunfox also carries a rare badge in Indian startup lore: it secured investment from all five investors on the first season of Shark Tank India.

Sunfox will use the Series A capital to expand domestically, grow its team, invest in R&D, clinical evidence, and engineering, and build regulatory, distribution, and commercial capabilities across priority international markets including the United States, Europe, and Africa.

What Spandan Actually Does

Spandan is a portable electrocardiogram platform developed by Sunfox that records heart activity and connects to smartphones, allowing frontline health workers — not just specialists — to capture ECGs that doctors review remotely. The platform can flag cardiac patterns requiring urgent attention, helping healthcare teams identify patients who need further assessment or treatment.

The product is designed for a hub-and-spoke model in public health systems: nurses or health workers at primary or community health centers record ECGs and share them with cardiologists at district hubs for review. Beyond the device, Spandan One is a digital platform for remote ECG review, case coordination, and tele-ECG network management.

The company says around 60,000 Spandan devices have been deployed across India, reaching more than 20,000 villages, while the Spandan One platform supports screening of approximately 5 million patients annually.

Regulatory Position

Sunfox says it has regulatory approvals in India, Ghana, Kenya, Tanzania, and South Africa, and is pursuing clearances in the United States and the European Union. It operates in more than 15 countries.

"This round gives us the resources to take what we have built in Dehradun to a much larger stage," said founder and CEO Rajat Jain. "We will invest deeply in R&D while expanding across India and building the capabilities required to take Sunfox and Spandan to global markets."

Lashit Sanghvi, co-founder of Alchemy Capital Management, said in a statement: "Sunfox has built a strong foundation in cardiac diagnostics with the potential to scale meaningfully from India to global markets. We believe its focus on innovation, accessibility and long-term value creation makes this an exciting next phase of growth."

Why It Matters for Founders and Investors

Sunfox is a textbook example of the "frugal medtech" thesis: build affordable, AI-enabled diagnostic hardware in India, prove it at massive scale in rural settings, then carry that cost advantage into regulated Western markets. Heart disease remains India's biggest killer, and the gap between cardiac events and specialist access is exactly the kind of problem that telemedicine hardware can close.

For founders, the pattern is instructive — a decade of R&D grind (founded 2016) followed by commercial scale, with clinical credibility and regulatory approvals compounding into a moat. For investors, the appeal is the margin structure of hardware-plus-platform plays: devices create the data network, and the network creates recurring diagnostic value. With US and EU clearances on the horizon, the next milestone to watch is whether Spandan can crack developed-market reimbursement.

Angeled.com connects founders with investors.

Read Next